News
The White House’s effort to lower drug prices in the U.S. is bringing higher drug prices to Europe. The Indiana-based drugmaker Eli Lilly said on Thursday that it is raising the list prices of its ...
The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...
The EMA's CHMP said the single pivotal US trial could serve as the basis for a marketing authorization application in the EU.
1d
TipRanks on MSNOcugen reports EMA positive advice for acceptability of OCU410ST
Ocugen (OCGN) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, reviewed the ...
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the ...
Access Conditionalities And Shortage Measures – A Comparison Of Commission/Parliament/Council Positions. Legal News and ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated’s (NASDAQ:INSM) Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic ...
2d
The Kenya Times on MSNOzempic and Other Weight-loss Drugs Linked to Rare But Serious Eye Conditions
Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
Collaboration Revenue: Collaboration revenue was $1.5 million for the three months ended June 30, 2025, as compared to no collaboration revenue for the three months ended June 30, 2024. The increase ...
Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2 Patients treated ...
On August 1, 2025, the European Court of Justice (ECJ) issued a judgment upholding the 2022 decision of the General Court ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results